Weight loss drugs could soon be used to treat these seven other health conditions - Eli Lilly and Novo Nordisk are actively ...

Eli Lilly (NYSE: LLY) has been a terrific investment in recent years. Thanks to significant clinical progress and outstanding ...

Double-digit prescription gains for its commercial drugs, major coverage wins, and the early launch of a new migraine therapy were the most significant highlights. Despite substantial progress, the ...

Biosimilars, once met with skepticism, are now an undeniable force in the global pharmaceutical market. As several ...

Breaking: The Gates Foundation said it would commit $2.5 billion through 2030 to support women’s health initiatives, its ...

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

The US pharmaceutical giant has already hired 100 professionals and plans to expand its headcount to 1,500 in the coming ...

Total 2Q 2025 net product revenue of $150.0 million, representing growth of 72% year-over-year and 24% sequentially AUVELITY® ...